rs1555756461
Positions:
Variant summary
Our verdict is Pathogenic. Variant got 13 ACMG points: 13P and 0B. PVS1PM2PP2PP5_Moderate
The NM_001127222.2(CACNA1A):c.2317_2319delGTGinsAC(p.Val773fs) variant causes a frameshift, missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Pathogenic (★). Variant results in nonsense mediated mRNA decay.
Frequency
Genomes: not found (cov: 32)
Consequence
CACNA1A
NM_001127222.2 frameshift, missense
NM_001127222.2 frameshift, missense
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 8.84
Genes affected
CACNA1A (HGNC:1388): (calcium voltage-gated channel subunit alpha1 A) Voltage-dependent calcium channels mediate the entry of calcium ions into excitable cells, and are also involved in a variety of calcium-dependent processes, including muscle contraction, hormone or neurotransmitter release, and gene expression. Calcium channels are multisubunit complexes composed of alpha-1, beta, alpha-2/delta, and gamma subunits. The channel activity is directed by the pore-forming alpha-1 subunit, whereas, the others act as auxiliary subunits regulating this activity. The distinctive properties of the calcium channel types are related primarily to the expression of a variety of alpha-1 isoforms, alpha-1A, B, C, D, E, and S. This gene encodes the alpha-1A subunit, which is predominantly expressed in neuronal tissue. Mutations in this gene are associated with 2 neurologic disorders, familial hemiplegic migraine and episodic ataxia 2. This gene also exhibits polymorphic variation due to (CAG)n-repeats. Multiple transcript variants encoding different isoforms have been found for this gene. In one set of transcript variants, the (CAG)n-repeats occur in the 3' UTR, and are not associated with any disease. But in another set of variants, an insertion extends the coding region to include the (CAG)n-repeats which encode a polyglutamine tract. Expansion of the (CAG)n-repeats from the normal 4-18 to 21-33 in the coding region is associated with spinocerebellar ataxia 6. [provided by RefSeq, Jul 2016]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 13 ACMG points.
PVS1
Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
PM2
Very rare variant in population databases, with high coverage;
PP2
Missense variant in gene, where missense usually causes diseases (based on misZ statistic), CACNA1A. . Gene score misZ: 5.7845 (greater than the threshold 3.09). Trascript score misZ: 3.9354 (greater than threshold 3.09). The gene has 137 curated pathogenic missense variants (we use a threshold of 10). The gene has 132 curated benign missense variants. GenCC has associacion of the gene with benign paroxysmal torticollis of infancy, developmental and epileptic encephalopathy, 42, undetermined early-onset epileptic encephalopathy, episodic ataxia type 2, familial or sporadic hemiplegic migraine, spinocerebellar ataxia type 6, Lennox-Gastaut syndrome, migraine, familial hemiplegic, 1.
PP5
Variant 19-13299314-CAC-GT is Pathogenic according to our data. Variant chr19-13299314-CAC-GT is described in ClinVar as [Pathogenic]. Clinvar id is 542835.Status of the report is criteria_provided_single_submitter, 1 stars.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CACNA1A | ENST00000360228.11 | c.2317_2319delGTGinsAC | p.Val773fs | frameshift_variant, missense_variant | 19/47 | 1 | NM_001127222.2 | ENSP00000353362.5 | ||
CACNA1A | ENST00000638029.1 | c.2329_2331delGTGinsAC | p.Val777fs | frameshift_variant, missense_variant | 19/48 | 5 | ENSP00000489829.1 | |||
CACNA1A | ENST00000573710.7 | c.2323_2325delGTGinsAC | p.Val775fs | frameshift_variant, missense_variant | 19/47 | 5 | ENSP00000460092.3 | |||
CACNA1A | ENST00000635727.1 | c.2320_2322delGTGinsAC | p.Val774fs | frameshift_variant, missense_variant | 19/47 | 5 | ENSP00000490001.1 | |||
CACNA1A | ENST00000637769.1 | c.2320_2322delGTGinsAC | p.Val774fs | frameshift_variant, missense_variant | 19/47 | 1 | ENSP00000489778.1 | |||
CACNA1A | ENST00000636012.1 | c.2320_2322delGTGinsAC | p.Val774fs | frameshift_variant, missense_variant | 19/46 | 5 | ENSP00000490223.1 | |||
CACNA1A | ENST00000637736.1 | c.2179_2181delGTGinsAC | p.Val727fs | frameshift_variant, missense_variant | 18/46 | 5 | ENSP00000489861.1 | |||
CACNA1A | ENST00000636389.1 | c.2320_2322delGTGinsAC | p.Val774fs | frameshift_variant, missense_variant | 19/47 | 5 | ENSP00000489992.1 | |||
CACNA1A | ENST00000637432.1 | c.2329_2331delGTGinsAC | p.Val777fs | frameshift_variant, missense_variant | 19/48 | 5 | ENSP00000490617.1 | |||
CACNA1A | ENST00000636549.1 | c.2320_2322delGTGinsAC | p.Val774fs | frameshift_variant, missense_variant | 19/48 | 5 | ENSP00000490578.1 | |||
CACNA1A | ENST00000637927.1 | c.2323_2325delGTGinsAC | p.Val775fs | frameshift_variant, missense_variant | 19/47 | 5 | ENSP00000489715.1 | |||
CACNA1A | ENST00000635895.1 | c.2320_2322delGTGinsAC | p.Val774fs | frameshift_variant, missense_variant | 19/47 | 5 | ENSP00000490323.1 | |||
CACNA1A | ENST00000638009.2 | c.2320_2322delGTGinsAC | p.Val774fs | frameshift_variant, missense_variant | 19/47 | 1 | ENSP00000489913.1 | |||
CACNA1A | ENST00000637276.1 | c.2320_2322delGTGinsAC | p.Val774fs | frameshift_variant, missense_variant | 19/46 | 5 | ENSP00000489777.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 genomes
Cov.:
32
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome Cov.: 32
GnomAD4 genome
Cov.:
32
ClinVar
Significance: Pathogenic
Submissions summary: Pathogenic:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Episodic ataxia type 2;C4310716:Developmental and epileptic encephalopathy, 42 Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 12, 2018 | This sequence change creates a premature translational stop signal (p.Val774Thrfs*43) in the CACNA1A gene. It is expected to result in an absent or disrupted protein product. This variant is not present in population databases (ExAC no frequency). This variant has not been reported in the literature in individuals with CACNA1A-related disease. Loss-of-function variants in CACNA1A are known to be pathogenic (PMID: 10371528, 19486177, 25735478, 27250579). For these reasons, this variant has been classified as Pathogenic. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at